cancer patients

Researchers from the Molecular Oncology and Viral Pathology Group (GOMPV) at the IPO-Porto Research Center (CI-IPOP), in collaboration with researchers from the Departments of Medical Oncology, Onco-Hematology, and Occupational Health at IPO-Porto, conducted a study on the immune response of cancer patients to the SARS-CoV-2 vaccination booster. The project focused on studying humoral immunity over time in patients who were undergoing active treatment when they received the vaccine booster dose, using a group of healthy individuals as a control.

Authors and Affiliations:
Rita F. Oliveira ^1,2, Ana I. Oliveira ¹, Agostinho Cruz ¹, Oscar Ribeiro ², Vera Afreixo ³ and Francisco Pimentel ⁴

¹ REQUIMTE/LAQV, ESS, Polytechnic of Porto, Rua Dr. António Bernardino de Almeida 400, 4200-072 Porto, Portugal

Authors and Affiliations:

João Lobo ^1,2,3, Carmen Jerónimo ^2,3,*,# and Rui Henrique ^1,2,3,*,#

¹ Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal

² Cancer Biology and Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (GEBC CI-IPOP) and Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal

Several experts from COST Action STRATAGEM - “New diagnostic and therapeutic tools against multidrug resistant tumors”, joined efforts to write an up-to-date, focused and thought-provoking review on the multi-disciplinary and interdisciplinary features of multidrug resistant cancers. It is necessary to identify and understand the various molecular mechanisms behind clinical multidrug resistance, in order to develop new targeted therapeutic strategies to overcome cancer therapeutic failure.

Vários especialistas da Acção COST STRATAGEM - “New diagnostic and therapeutic tools against multidrug resistant tumors”, reuniram esforços para escrever uma revisão atualizada, desafiante e focada nas características multidisciplinares e interdisciplinares dos cancros com resistência a múltiplos fármacos. É necessário identificar e entender os vários mecanismos moleculares responsáveis pela resistência clínica a múltiplos fármacos anticancerígenos, de modo a desenvolver novas estratégicas terapêuticas dirigidas que permitam ultrapassar a falência da terapêutica.

Business Design Centre, London, United Kingdom

23 - 24 September, 2016

See more informations here: http://www.map-onco.net/

Business Design Centre, London, United Kingdom

23 - 24 September, 2016

See more informations here: http://www.map-onco.net/

Rode Hoed’s Great Hall, Amsterdam, Netherlands

09-11 May, 2016

See more informations here: http://www.eacr.org/mpathcourse2016/index.php

Rode Hoed’s Great Hall, Amsterdam, Netherlands

09-11 May, 2016

See more informations here: http://www.eacr.org/mpathcourse2016/index.php

Study conducted in two hospitals of Porto revealed that acupuncture has beneficial effects in cancer patients undergoing chemotherapy, including the improvement of the immune system, reduction of chemotherapy side effects, improving the psychoemotional state as well as improving the patients' quality of life.

Authors and Affiliations: